
    
      This is a Phase I, open-label, single arm study to demonstrate the safety of Antria Cell
      Preparation Process during fat grafting augmented with autologous adipose derived stromal
      vascular fraction to demonstrate the safety and efficacy of administration of SVF enriched
      fat grafting in chronic wounds.
    
  